Corteva buys out New Zealand agri-biotech Biotelliga for $90M
What's the deal? CortevaDealroom has a profile for this one. Try Dealroom → has acquired the remaining 80% stake it did not already own in BiotelligaDealroom has a profile for this one. Try Dealroom →, a New Zealand-based agricultural biotechnology company developing solutions for managing crop pests and diseases. The deal values the buyout at $90 million.
What's the endgame? Corteva intends to keep operating the business out of New Zealand, tapping Biotelliga's microbial library to expand its lineup of bio-pesticides and sustainable farming products.
Why it matters: Full ownership deepens Corteva's push into biological crop protection, a market drawing capital as growers and regulators look for lower-impact alternatives to synthetic pesticides.
Read more: Everchem
